Ravikanth Kona

发表

Quality-by-Design II: Application of Quantitative Risk Analysis to the Formulation of Ciprofloxacin Tablets

Stephen W. Hoag, H. Gregg Claycamp, Ravikanth Kona, 2015, AAPS PharmSciTech.

Quality by Design I: Application of Failure Mode Effect Analysis (FMEA) and Plackett–Burman Design of Experiments in the Identification of “Main Factors” in the Formulation and Process Design Space for Roller-Compacted Ciprofloxacin Hydrochloride Immediate-Release Tablets

Ravikanth Kona, Raafat Fahmy, Walter Xie, 2012, AAPS PharmSciTech.

Application of in-line near infrared spectroscopy and multivariate batch modeling for process monitoring in fluid bed granulation.

Haibin Qu, Stephen W Hoag, Ravikanth Kona, 2013, International journal of pharmaceutics.

United States Food and Drug Administration and Department of Defense shelf-life extension program of pharmaceutical products: progress and promise.

Abhay Gupta, Ravikanth Kona, Patrick J Faustino, 2014, Journal of pharmaceutical sciences.